Machine learning-driven drug repurposing for HER2-positive breast cancer

Zhang, Y. et al. Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN. J. Natl. Cancer Cent. 5 (3), 287 (2025).
• Qu, Z. et al. Global, Regional, and National Burden of Breast Cancer in Adolescents and Young Adults Aged 15–39 Years From 1990 to 2021 Based on the Global Burden of Disease Study 2021. Cancer Innov. 4 (4), e70016 (2025).
• Gaber, D. M. et al. A drug repurposing approach of Atorvastatin calcium for its antiproliferative activity for effective treatment of breast cancer: In vitro and in vivo assessment. Int. J. Pharmaceutics: X. 7, 100249 (2024).…Read more by Storrs, Alliance University, Srinivas, Department of Biotechnology, School of Physics, Materials, USA, Kumarappan, Basavana Gowda Hosur, Chidambaram, Mohankumar, College of Pharmacy, Kumar, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Parasuraman, China, Prabu Kumar, Bengaluru, M.S. Ramaiah University of Applied Sciences, Ammunje, Laboratory of Functional Molecules, Dinesh, Saudi Arabia, King Khalid University, Abha, Selvaraj, Department of Pharmacology, Bandral Sunil, Ramar, Pavadai, Pharmaceutical Sciences, Optoelectronic Engineering, Shandong University of Technology, Ganjipete, Zibo, UConn School of Pharmacy, Seetharaman, India, Kunjiappan, Damodar Nayak